Carregant...

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have emerged as alternatives to VKAs for the prevention of stroke in patients with non-valvular atrial fibrillation. Four NOACS: dabigatran, apixaban, rivaroxaban and edoxaban, have received regulatory approval in Europe from the European Me...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arrhythm Electrophysiol Rev
Autor principal: Alings, Marco
Format: Artigo
Idioma:Inglês
Publicat: Radcliffe Cardiology 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013151/
https://ncbi.nlm.nih.gov/pubmed/27617088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/AER.2016.20.3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!